Petros
Electricity, Oil & Gas · Malaysia · <25 Employees
View Company Info for Free
About
Headquarters
Wisma Bapa Malaysia Petra Jaya Fl 22, Kuching, ...Website
www.petros.myRevenue
<$5 MillionIndustry
Who is Petros
Trailing Petroleum Sarawak Berhad on Petros.
Petros Org Chart
Is Petros your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Petros had a recent Job posting/layoffs
Check out if Petros is spiking on competitors!
Earning: See what the market has to say on Petros recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Petros has new funding data
Petros, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Petros launches new products
Check if Petros has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Petros
Recommended Actions
Reach out to Masked Content who joined Petros as Masked Content
Find more new buyers
Petros Employee Growth Rate
View Petros’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
Most Recent Scoops
Last Week
Hot Scoop - Business
Last month
Hot Scoop - Financial
Last month
Hot Scoop - Opportunities
Petros News & Media
Petros Pharmaceuticals Expands Program for Novel Investigational Non-Invasive Treatment Formulation for Peyronie's Disease
NEW YORK, Nov. 8, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today the expansion of its program for investigational H100, a novel patented non-invasive topical treatment under development for Peyronie's...
Petros Pharmaceuticals Announces First Quarter Financial Results and Provides Corporate Update; Reports 300% increase in Year-Over-Year STENDRA Net Sales
NEW YORK, May 17, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Petros or the Company) (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced financial results for the first quarter ended March 31, 2021. First Quarter Highlights: 300% increase in...Recently Published Research on Stendra®(avanafil) for Endothelial Function in Men with Erectile Dysfunction to Initiate Petros Pharmaceuticals' Plans for Expanded Labeling
NEW YORK, March 18, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Petros or the Company) (NASDAQ: PTPI), a leading provider of therapeutics for men's health, today announced the publication of preliminary research on the investigational use of Stendra® (avanafil) for endothelial...Petros Pharmaceuticals Establishes Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)
NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Petros or the Company) (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that it has formed a steering committee to develop expanded patient access initiatives, including...
Read more news
Frequently Asked Questions Regarding Petros
Trailing Petroleum Sarawak Berhad on Petros.... Read More
